Results 91 to 100 of about 16,622 (148)

Aerosol vaccination with tetanus toxoid [PDF]

Bacteriological Reviews, 1966
J M Magis, H M Yamashiroya, R Ehrlich
openaire   +3 more sources

Suspected Diphtheria Toxoid and Tetanus Toxoid (dTdap) Booster Vaccine-Induced Postural Orthostatic Tachycardia Syndrome (POTS). [PDF]

Cureus
Katwaroo AR, Chandolu KM, Seecheran VK, Ramcharan P, Seecheran RV, Giddings S, Bhagwandass N, Seecheran NA.   +7 more
europepmc   +1 more source

Perinatal mortality and its association with antenatal care visit, maternal tetanus toxoid immunization and partograph utilization in Ethiopia: a meta-analysis. [PDF]

Sci Rep, 2021
Desta M, Akalu TY, Alamneh YM, Talie A, Alemu AA, Tessema Z, Yibeltal D, Alamneh AA, Ketema DB, Shiferaw WS, Getaneh T.   +10 more
europepmc   +1 more source

Impact of the US Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccination Program on Preventing Pertussis in Infants 2 to <6 Months of Age: A Case-Control Evaluation. [PDF]

Open Forum Infect Dis
Skoff TH, Rubis AB, Kirley PD, Scherzinger K, McMahon M, McGuire S, Kudish K, Cieslak PR, Shang N, Hariri S.   +9 more
europepmc   +1 more source

Effects of the Prenatal Administration of Tetanus Toxoid on the Sociability and Explorative Behaviors of Rat Offspring: A Preliminary Study. [PDF]

Clin Psychopharmacol Neurosci, 2021
Sünnetçi E, Durankuş F, Albayrak Y, Erdoğan MA, Atasoy Ö, Erbaş O, Erbaş O.   +6 more
europepmc   +1 more source

Tetanus toxoid

, 2013
Tejpratap S.P. Tiwari, Walter A. Orenstein, Martha H. Roper, Steven G. F. Wassilak   +3 more
openaire   +2 more sources

Safety, immunogenicity and non-interference of concomitant Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV®) and measles or measles-mumps-rubella vaccines in 8-9 months-old Indian children. [PDF]

Hum Vaccin Immunother, 2022
Vadrevu KM, Dugyala R, Mahantashetti NS, Khalatkar V, Murthy K, Mogre S, Mitra M.   +6 more
europepmc   +1 more source

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in children aged 10-12 years: phase III randomized trial complementary analysis of immune persistence 3-6 years after priming. [PDF]

Pediatr Res
Peterson J, Galarza K, Bchir S, Zocchetti C, Bertrand-Gerentes I, Zambrano B.   +5 more
europepmc   +1 more source

A multi-centre, post-marketing surveillance study of Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar TCV®) in India. [PDF]

Hum Vaccin Immunother, 2022
Reddy R, Reddy B, Sarangi V, Reddy S, Ella R, Vadrevu KM.   +5 more
europepmc   +1 more source

Uptake of protective tetanus toxoid vaccine doses and maternal associated factors during pregnancy in armed conflict zone, hospital-based cross-sectional study. [PDF]

Front Reprod Health
Kebede Bizuneh F, Muhidin Mustofa S.
europepmc   +1 more source